In a challenging year for Aclarion, the medical technology company's stock has plummeted to a 52-week low, trading at $4.41. According to InvestingPro data, the company maintains a healthy liquidity ...

Aclarion, Inc. (NASDAQ: ACON) shares cleared breakeven Tuesday, as the health-care technology company announced it has received a Notice of Allowance from the United States Patent and Trademark Office ...

BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ:ACON, ACONW), a healthcare technology company, announced today it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent ...

Aclarion (ACON) has received a Notice of Allowance from the United States Patent and Trademark Office for its 24th issued US patent. Whereas ...

The spinal implants market is estimated to grow by $3.55 billion from 2025 to 2029, according to research from Technavio.

Chicago-based Northwestern Medicine will be the first site for Clarion's Clarity trial for spine surgery, according to a Feb. 6 news release.

Northwestern Medicine is a global leader in clinical trial research, including spine CLARITY is a randomized study designed ...

As artificial intelligence continues to evolve, investors are closely watching the opportunities emerging in both private and ...

Aclarion stock is trading higher on Tuesday after the company announced it secured funding for its CLARITY trial of its ...

We recently compiled a list of the 12 AI News and Ratings You Should Not Miss. In this article, we are going to take a look ...